Xuguang Grant Tao1, Robert A Lavin, Larry Yuspeh, Virginia M Weaver, Edward J Bernacki. 1. From the Department of Medicine (Drs Tao and Bernacki), Division of Occupational and Environmental Medicine, Johns Hopkins University School of Medicine; Department of Neurology (Dr Lavin), University of Maryland School of Medicine, Baltimore; Department of Strategic Risk and Strategy Management (Mr Yuspeh), Louisiana Workers' Compensation Corporation; and Department of Environmental Health Sciences and Medicine (Dr Weaver), Johns Hopkins University Medical Institutions, Baltimore, Md.
Abstract
OBJECTIVE: To study the relationship between the use of psychotropic and opioid medications with workers' compensation disability and costs. METHODS: The study population included lost time claimants injured between 1999 and 2002 followed to closing in December 31, 2009. RESULTS: Controlling for age, sex, marital status, attorney involvement, and spinal surgeries, multivariate logistic regression revealed that odds ratios (95% confidence interval) of claim costs ≥$100,000 compared with claimants who were never prescribed opioids were 4.3 for short-acting opioids only; 8.6 for any use of long-acting opioids; 2.8 for any use of hypnotics; 2.6 for any use of antipsychotics; 1.6 for any use of anti-anxiety agents; and 2.9 for any use of antidepressants. CONCLUSIONS: The use of psychotropic and opioid medications was associated with high workers' compensation costs and prolonged disability.
OBJECTIVE: To study the relationship between the use of psychotropic and opioid medications with workers' compensation disability and costs. METHODS: The study population included lost time claimants injured between 1999 and 2002 followed to closing in December 31, 2009. RESULTS: Controlling for age, sex, marital status, attorney involvement, and spinal surgeries, multivariate logistic regression revealed that odds ratios (95% confidence interval) of claim costs ≥$100,000 compared with claimants who were never prescribed opioids were 4.3 for short-acting opioids only; 8.6 for any use of long-acting opioids; 2.8 for any use of hypnotics; 2.6 for any use of antipsychotics; 1.6 for any use of anti-anxiety agents; and 2.9 for any use of antidepressants. CONCLUSIONS: The use of psychotropic and opioid medications was associated with high workers' compensation costs and prolonged disability.
Authors: Michele Kowalski-McGraw; Judith Green-McKenzie; Sudha P Pandalai; Paul A Schulte Journal: J Occup Environ Med Date: 2017-11 Impact factor: 2.162
Authors: Sara E Heins; Christine Buttorff; Courtney Armstrong; Rosalie Liccardo Pacula Journal: Drug Alcohol Depend Date: 2021-09-22 Impact factor: 4.492
Authors: Antoni Sicras-Mainar; Juan Carlos Tornero-Tornero; Francisco Vargas-Negrín; Isabel Lizarraga; Aram Sicras-Navarro; Javier Rejas-Gutierrez Journal: Open Access Rheumatol Date: 2022-03-15